Tobacco News and Research

RSS

Study: Less than 50% of U.S. adults exposed to court-ordered anti-smoking advertisements

The tobacco industry's court-ordered anti-smoking advertisements reached just 40.6% of U.S. adults and 50.5% of current smokers in 2018, according to new research from The University of Texas MD Anderson Cancer Center.

15 Jul 2019

Effective stop smoking treatments less likely to be prescribed to people with mental health conditions

A new study from researchers at the Universities of Bath and Bristol suggests that doctors should rethink which drugs they prescribe to help smokers with mental health conditions kick the habit.

11 Jul 2019

Mice study could lead to potential treatment for vestibular disorders

Researchers at the Stanford University School of Medicine have found a way to regenerate hair cells in the inner ears of mice, allowing the animals to recover vestibular function. It's the first time such recovery has been observed in mature mammals.

10 Jul 2019

Study: Cardiac rehab programs are available in only half of the world's countries

More than 20 million people develop heart disease globally each year, but there is only one cardiac rehab spot for every 12 of those patients to prevent another heart event, according to new research from York University.

8 Jul 2019

Study: 1 in 3 people with hypertension don't monitor their condition and 1 in 5 don't follow any treatment

Study conducted as part of blood pressure-measuring campaign MMM18 shows that that one in three people with hypertension don't monitor it (35.5%), and one in five don't follow any sort of treatment (19%).

7 Jul 2019

$FDA grants accelerated approval to new treatment for refractory multiple myeloma$

FDA grants accelerated approval to new treatment for refractory multiple myeloma

Today, the U.S. Food and Drug Administration granted accelerated approval to Xpovio (selinexor) tablets in combination with the corticosteroid dexamethasone for the treatment of adult patients with relapsed refractory multiple myeloma who have received at least four prior therapies and whose disease is resistant to several other forms of treatment, including at least two proteasome inhibitors, at least two immunomodulatory agents, and an anti-CD38 monoclonal antibody.

3 Jul 2019

Smoking triples the risk of death from cardiovascular disease

Smoking is killing at least 17 Australians a day from preventable heart attacks, strokes and other cardiovascular conditions, new research led by The Australian National University has found.

3 Jul 2019

Smoke-free generation ‘in sight’ as numbers of smokers drop dramatically

Health experts are predicting that future generations could be “smoke-free” after numbers of smokers dropped dramatically since 2011.

3 Jul 2019

Probiotic containing common gut bacterium could halve cardiovascular disease rates

A small study has found that supplements of the gut bacterium, A. muciniphila, may cut cardiovascular disease rates in half.

3 Jul 2019

Cancer Research UK urges Government action to tackle obesity

New figures from Cancer Research UK show that people who are obese now outnumber people who smoke two to one in the UK, and excess weight causes more cases of certain cancers than smoking, as the charity urges Government action to tackle obesity.

3 Jul 2019

Electronic cigarettes produce stress response in neural stem cells, study finds

A research team at the University of California, Riverside, has found that electronic cigarettes, often targeted to youth and pregnant women, produce a stress response in neural stem cells, which are critical cells in the brain.

1 Jul 2019

Concurrent use of benzodiazepine and opioids complicates neonatal abstinence syndrome

Babies born after being exposed to both opioids and benzodiazepines before birth are more likely to have severe drug withdrawal, requiring medications like morphine for treatment, compared to infants exposed to opioids alone, according to a Vanderbilt University Medical Center study published in Hospital Pediatrics.

1 Jul 2019

Cells in humans are affected by thirdhand smoke, study shows

Thirdhand smoke can damage epithelial cells in the respiratory system by stressing cells and causing them to fight for survival, a research team led by scientists at the University of California, Riverside, has found. The finding could assist physicians treating patients exposed to thirdhand smoke.

28 Jun 2019

FDA approves first drug for treatment of neuromyelitis optica spectrum disorder

The U.S. Food and Drug Administration today approved Soliris (eculizumab) injection for intravenous use for the treatment of neuromyelitis optica spectrum disorder in adult patients who are anti-aquaporin-4 antibody positive.

27 Jun 2019

Senate panel makes surprisingly fast work of ‘surprise medical bills’ package

It may seem as if the Senate, or at least certain key senators, have decided on a way forward to fix the nation's "surprise medical bill" problem. But make no mistake: The door is still open to try another solution.

26 Jun 2019

First treatment approved by FDA for chronic rhinosinusitis with nasal polyps

The U.S. Food and Drug Administration today approved Dupixent (dupilumab) to treat adults with nasal polyps (growths on the inner lining of the sinuses) accompanied by chronic rhinosinusitis (prolonged inflammation of the sinuses and nasal cavity).

26 Jun 2019

San Francisco set to ban sales of e-cigarettes

San Francisco's Board of Supervisors is slated to vote Tuesday to ban the sale and distribution of e-cigarettes in the city. The city is the corporate home of Juul Labs, the biggest producer of e-cigarettes in the country.

25 Jun 2019

Low rates of recommended treatment for tobacco dependence in patients hospitalized with SUDs

Tobacco dependence is very common in patients hospitalized with substance use disorders (SUDs) – but most don't receive recommended treatment for tobacco dependence while in the hospital, reports a study in the Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine

24 Jun 2019

Studies show no evidence of fall in cigarette consumption due to WHO’s FCTC

There is no statistical evidence that global cigarette consumption has fallen as a result of the World Health Organization's Framework Convention on Tobacco Control, and in low- and middle-income countries it has actually increased, according to two studies led by global health researchers at York University.

24 Jun 2019

FDA approves new drug to treat hypoactive sexual desire disorder in premenopausal women

The U.S. Food and Drug Administration today approved Vyleesi (bremelanotide) to treat acquired, generalized hypoactive sexual desire disorder in premenopausal women.

23 Jun 2019

Tobacco News and Research

Study: Less than 50% of U.S. adults exposed to court-ordered anti-smoking advertisements

Effective stop smoking treatments less likely to be prescribed to people with mental health conditions

Mice study could lead to potential treatment for vestibular disorders

Study: Cardiac rehab programs are available in only half of the world's countries

Study: 1 in 3 people with hypertension don't monitor their condition and 1 in 5 don't follow any treatment

FDA grants accelerated approval to new treatment for refractory multiple myeloma

Smoking triples the risk of death from cardiovascular disease

Smoke-free generation ‘in sight’ as numbers of smokers drop dramatically

Probiotic containing common gut bacterium could halve cardiovascular disease rates

Cancer Research UK urges Government action to tackle obesity

Electronic cigarettes produce stress response in neural stem cells, study finds

Concurrent use of benzodiazepine and opioids complicates neonatal abstinence syndrome

Cells in humans are affected by thirdhand smoke, study shows

FDA approves first drug for treatment of neuromyelitis optica spectrum disorder

Senate panel makes surprisingly fast work of ‘surprise medical bills’ package

First treatment approved by FDA for chronic rhinosinusitis with nasal polyps

San Francisco set to ban sales of e-cigarettes

Low rates of recommended treatment for tobacco dependence in patients hospitalized with SUDs

Studies show no evidence of fall in cigarette consumption due to WHO’s FCTC

FDA approves new drug to treat hypoactive sexual desire disorder in premenopausal women

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News